Varicella-Zoster Global Clinical Trials Review, Q1, 2011

GlobalData, March 2011, Pages: 35

Varicella-Zoster Global Clinical Trials Review, Q1, 2011

Summary

GlobalData's clinical trial report, “Varicella-Zoster Global Clinical Trials Review, Q1, 2011" provides data on the Varicella-Zoster clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Varicella-Zoster. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Varicella-Zoster. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Tables
List of Figures
Introduction
Varicella-Zoster
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Varicella-Zoster
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Varicella-Zoster Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Sanofi-Aventis
Clinical Trial Overview of Sanofi-Aventis
Sanofi Pasteur MSD
Clinical Trial Overview of Sanofi Pasteur MSD
Cangene Corporation
Clinical Trial Overview of Cangene Corporation
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Tazuke Kofukai Medical Research Institute
Clinical Trial Overview of Tazuke Kofukai Medical Research Institute
KITANO HOSPITAL
Clinical Trial Overview of KITANO HOSPITAL
University of Sao Paulo General Hospital
Clinical Trial Overview of University of Sao Paulo General Hospital
University of Colorado
Clinical Trial Overview of University of Colorado
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Varicella-Zoster Therapeutics Market, Global, Clinical Trials by Zone, 2011-
Varicella-Zoster Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Varicella-Zoster Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Varicella-Zoster Therapeutics Clinical Trials, Asia-Pacific , Top Five Countries, 2011-
Varicella-Zoster Therapeutics Clinical Trials, Europe, Top Five Countries, 2011-
Varicella-Zoster Therapeutics Clinical Trials, North America, Top Countries, 2011-
Varicella-Zoster Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011-
Varicella-Zoster Therapeutics Clinical Trials, BRIC Countries, 2011-
Varicella-Zoster Therapeutics Market, Global, Clinical Trials by Phase, 2011-
Varicella-Zoster Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011-
Varicella-Zoster Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Varicella-Zoster Therapeutics Market, Global, Suspended Clinical Trials, 2011-
Varicella-Zoster Therapeutics Market, Global, Terminated Clinical Trials, 2011-
Varicella-Zoster Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Varicella-Zoster Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Varicella-Zoster Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Varicella-Zoster Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
Varicella-Zoster Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011-
Varicella-Zoster Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011-
Varicella-Zoster Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis, 2011-
Varicella-Zoster Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi Pasteur MSD, 2011-
Varicella-Zoster Therapeutics Clinical Trials Market, Global, Clinical Trials by Cangene Corporation, 2011-
Varicella-Zoster Therapeutics Clinical Trials Market, Global, Clinical Trials by Tazuke Kofukai Medical Research Institute, 2011-
Varicella-Zoster Therapeutics Clinical Trials Market, Global, Clinical Trials by KITANO HOSPITAL, 2011-
Varicella-Zoster Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo General Hospital, 2011-
Varicella-Zoster Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2011-

List of Figures
Varicella-Zoster Therapeutics Market, Global, Clinical Trials by Zone (%), 2011-
Varicella-Zoster Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Varicella-Zoster Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Varicella-Zoster Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011-
Varicella-Zoster Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011-
Varicella-Zoster Therapeutics Clinical Trials, North America, Top Countries (%), 2011-
Varicella-Zoster Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011-
Varicella-Zoster Therapeutics Clinical Trials, BRIC Countries (%), 2011-
Varicella-Zoster Therapeutics Market, Global, Clinical Trials by Phase (%), 2011-
Varicella-Zoster Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011-
Varicella-Zoster Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Varicella-Zoster Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Varicella-Zoster Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Varicella-Zoster Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Varicella-Zoster Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
Methodology

Customers who bought this item also bought

• Varicella Zoster (HHV-3) Infections - Pipeline Review, H2 2012
• Herpes Zoster (Shingles) - Pipeline Review, H2 2012
• Inhibitex's FV-100 - Will this promising new treatment for shingles live up to its potential?
• Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers
• Competitor Analysis: Herpes Virus Vaccines and Therapeutics
• Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth
• Nasal Congestion Global Clinical Trials Review, H1, 2013
• Strabismus Global Clinical Trials Review, H1, 2013
• Emerging Market for Clinical Trials in Argentina - Major Cost Advantages over the US in Conducting Clinical Trials Will Encourage Drug Development
• Bronchitis Global Clinical Trials Review, H2, 2012